A Case of Urachal CarcinomaRyan Griffin1,2, Laura Alder2, Brian Baksa2, Brendon Keith2, Do Young Kim2 and Marc R. Matrana1,2*
- *Corresponding Author:
- Marc R. Matrana
MD, MSc, Third Floor, Benson Cancer Center
Ochsner Clinic Foundation
1514 Jefferson Highway
New Orleans, LA 70121, USA
Tel: +(504) 842-3910
E-mail: mamatran[email protected]
Received date: December 31, 2015 Accepted date: February 01, 2016 Published date: February 08, 2016
Citation: Griffin R, Alder L, Baksa B, Keith B, Kim DY, et al. (2016) A Case of Urachal Carcinoma. Med Surg Urol 5:158. doi: 10.4172/2168-9857.1000158
Copyright: © 2016 Griffin R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Urachal carcinoma is a rare, non-urothelial carcinoma that represents less than one percent of all bladder cancers. We present the case of a 58-year-old man who presented with the acute onset of painless hematuria. Cystoscopy revealed a bladder mass, and subsequent biopsy of a liver mass confirmed the diagnosis of metastatic urachal adenocarcinoma. The patient initially underwent a chemotherapeutic regimen of 5-fluorouracil, leucovorin, gemcitabine, and cisplatin (GEM-FLP) given every four weeks. Our case illustrates the importance of recognizing and diagnosing urachal carcinoma correctly since the therapeutic options differ compared to traditional urothelial cancers.